That little blue pill Viagra has been making men randy and ready for 16 years now. But a pink pill to lift female libido has been as elusive as the male contraceptive tablet.
This week, it might actually be closer to approval. After a clever (and rather dodgy) campaign, the US Food and Drug Administration will now reconsider a female desire drug it rejected just a few years ago.
Viagra works by increasing blood flow to the genitals. Some women such as Kim Cattrell, and her alter ego Sex and the City’s Samantha, found it also helps them achieve a higher sex drive and better orgasms.
“It does the same thing for the clitoris as for the penis,” Cattrell said.
But Viagra just doesn’t do it for most women.
Enter the female sex dug Flibanserin, which - recognising that for women sex is less about our genitals and more about desire - works on the brain. It's a pill that has to be taken every day and acts on the chemicals that deal with mood, increasing "excitatory factors for sex" - dopamine and norepinephrine - and decreasing serotonin, which can dampen the sex drive.
Originally developed as an anti-depressant, the drug company Sprout says the drug boosts sexual desire, reduces stress and increases "sexually satisfying events" for women with hypoactive sexual desire disorder - a lack of sexual appetite that causes stress.
Experiments have shown the so-called 'pink viagra' increased sexual activity among participants.























